[Cancer. 35th Congress of the American Society of Clinical Oncology (ASCO), Atlanta, 15-18 May 1999].
Louvet
C
C
D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000601:surgery; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000556:secondary; D003131:Combined Modality Therapy; D004067:Digestive System Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D005845:Georgia; D006801:Humans; D008495:Medical Oncology; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D011379:Prognosis; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D012955:Societies, Medical; D013274:Stomach Neoplasms / Q000188:drug therapy; D013997:Time Factors; D014481:United States
D000970:Antineoplastic Agents